<?xml version="1.0" encoding="UTF-8"?>
<p>Protease inhibitors (PI) specifically bind to the active site of the protease and therefore prevent viral replication. Several PIs have been used for successful treatment of HIV. Nevertheless, side effects and development of viral resistance were found during treatment, and therefore additional compounds that bind to sites other than the active site of the protease have been developed [
 <xref rid="B85-vetsci-02-00456" ref-type="bibr">85</xref>,
 <xref rid="B86-vetsci-02-00456" ref-type="bibr">86</xref>,
 <xref rid="B87-vetsci-02-00456" ref-type="bibr">87</xref>].
</p>
